Could a Kids' chemo recipe tame adult leukemia?

NCT ID NCT01920737

First seen Nov 01, 2025 · Last updated May 08, 2026 · Updated 32 times

Summary

This study tests whether a chemotherapy plan used for children with acute lymphoblastic leukemia (ALL) can work safely and effectively in adults aged 18 to 60 with a specific type of ALL (Philadelphia chromosome-negative). The goal is to see if this approach can wipe out the leukemia at a deep level (called molecular remission) while reducing harsh side effects. About 39 adults will receive this treatment to find out if it offers a better balance of effectiveness and tolerability compared to standard adult regimens.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LEUKEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Duke University Medical Center

    Durham, North Carolina, 27701, United States

  • Memorial Sloan Kettering Cancer Center

    New York, New York, 10065, United States

  • Weill Cornell Medical Center

    New York, New York, United States

Conditions

Explore the condition pages connected to this study.